IFF’s Deep‑Value Play: Givaudan Gap and New Share Buyback

International Flavors & Fragrances (IFF) has entered the radar of deep‑value investors, poised to close the pricing gap with its industry peers.

Valuation Gap and Peer Benchmarking

■IFF closed on July 14, 2026 at $74.67, giving it a market cap of $19.06 bn.

■While sector leader Givaudan trades at a forward EBITDA multiple of 19.14×, IFF is priced at a modest 12.23×.

■The disparity is underpinned by a 37% growth‑driven Health & Biosciences segment and a 32% contribution from the Scent division.

Heartland Mid Cap Value Fund’s Strategic Emphasis

■The fund delivered a 9.90% return in Q2 2026, lagging the Russell Midcap® Value Index which posted 13.40%.

■Fund managers highlighted IFF as a “self‑help” opportunity, emphasizing its low valuation and improving profit margins.

■The launch of the first share buyback in six years signals management’s confidence in narrowing the valuation gap.

Financial Snapshot and Performance Metrics

■52‑week total return: +0.61%.

■One‑month performance: ‑1.81%.

■Revenue split: Taste 30%, Health & Biosciences 37%, Scent 32%.

■Operational efficiency gains and rising free cash flow are aligning the company’s profile with industry leader Givaudan.

Outlook and Potential Catalysts

■Ongoing portfolio and operational simplification is accelerating focus on high‑margin businesses.

■Leadership in encapsulated fragrance technology opens expansion into new consumer categories such as fabric care, shampoos, and body washes.

■Closing the valuation gap could unlock a 20‑30% upside in the stock price.

Markets are watching IFF’s modest multiple and expanding margins closely; this scenario is viewed as a leading indicator of sector‑wide re‑pricing, especially as raw‑material costs stabilize. For fund managers and value investors, the dynamics bolster the long‑term return potential of IFF shares.